About this trial

This program collects genetic and health information to help doctors choose the right medications for patients.

Eligibility criteria

Qualifiers

The study will invite patients who are eligible for PGX workup/PGX care to participate, provided they meet the following criteria: Use of five or more medications, including over the counter drugs, supplements, natural products, cannabis products, or other recreational drugs, or

Individuals taking blood pressure or depression medications, even if less than five medications.

Ability to understand and give consent.

Able to consent to donate blood and/or urine samples and buccal swabs.

Disqualifiers

Individuals admitted to hospice.

Declines to participate or interact with staff/share their medical status.

A diagnosis of Alzheimer's disease or related dementias in a medical record as this indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning.,

Individuals who are unable or unwilling to provide consent.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

3,000 Participants
are grouped into 1 trial group

Locations

1
Texas A&M Family Care77802, BryanTexas, United States

Sponsors and collaborators

Texas A&M University

Lead sponsor